1. SHOX2 and SEPT9 methylation is a potential biomarker for the diagnosis of biliary tract cancer. (2019) Authors: Branchi, V.; Schaefer, P.; Semaan, A.; Linghor, P.; Kalff, J.C.; Schäfer, N.; Christiansen, G.; Dietrich, D.; Matthaei, H. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S1018 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SHOX2 and SEPT9 Methylation is a potential biomarker for the diagnosis of biliary tract cancer. (2019) Authors: Branchi, V.; Schaefer, P.; Semaan, A.; Linghor, P.; Kalff, J.C.; Schäfer, N.; Christiansen, G.; Dietrich, D.; Matthaei, H. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗